Delayed functional loss in glaucoma - LII Edward Jackson Memorial Lecture

被引:117
作者
Brubaker, RF
机构
[1] Mayo Clinic, Rochester, MN 55905
关键词
D O I
10.1016/S0002-9394(14)75421-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: This study is a systematic exploration of why some patients with glaucoma continue to lose visual field long after therapeutic normalization of their increased intraocular pressures. METHODS: Three cases of glaucoma are described that had increased intraocular pressures and good initial visual fields. RESULTS: The following four hypotheses are offered to explain delayed functional loss in these patients: (1) A process independent of intraocular pressure is killing ganglion cells. (2) Unmeasured increases of pressure are killing ganglion cells, (3) The ganglion cells have a generically determined hypersensitivity to intraocular pressure. (4) The ganglion cells have been rendered hypersensitive to intraocular pressure by irreversible damaging effects of previously increased intraocular pressures. CONCLUSION: The current state of knowledge does not permit the elimination of any of the four hypotheses. An additional hypothesis is that the final stage of ganglion cell death is mediated by apoptosis. If so, a potential new treatment for glaucoma would be to inhibit the apoptotic pathway.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 72 条
[1]   OPTIC DISK HEMORRHAGES PRECEDE RETINAL NERVE-FIBER LAYER DEFECTS IN OCULAR HYPERTENSION [J].
AIRAKSINEN, PJ ;
MUSTONEN, E ;
ALANKO, HI .
ACTA OPHTHALMOLOGICA, 1981, 59 (05) :627-641
[2]  
AIRAKSINEN PJ, 1983, 5 INT VIS FIELD S HA, P11
[3]  
ALBEDIN S, 1982, OPHTHALMOLOGY, V89, P1
[4]   THE PROTOONCOGENE BCL-2 CAN SELECTIVELY RESCUE NEUROTROPHIC FACTOR-DEPENDENT NEURONS FROM APOPTOSIS [J].
ALLSOPP, TE ;
WYATT, S ;
PATERSON, HF ;
DAVIES, AM .
CELL, 1993, 73 (02) :295-307
[6]  
ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771
[7]  
ANDERSON DR, 1975, GLAUCOMA, P81
[8]  
BECKER B, 1971, AM J OPHTHALMOL, V71, P1
[9]  
BENGTSSON B, 1981, ACTA OPHTHALMOL, V59, P1
[10]  
CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898